Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-05-02
1997-04-22
Chan, Christina Y.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241301, 4241331, 4241411, 4241431, 4241521, 4241531, 4241541, 4241721, 4241731, A61K 39395
Patent
active
056227000
ABSTRACT:
A method is provided for administering to a mammal suffering from, or at risk for, a LFA-1-mediated disorder an initial dosing of a therapeutically effective amount of LFA-1 antagonist, followed by a subsequent intermittent dosing of a therapeutically effective amount of LFA-1 antagonist that is less than 100%, calculated on a daily basis, of the initial dosing of antagonist.
REFERENCES:
patent: 4797277 (1989-01-01), Arfors
patent: 5002869 (1991-03-01), Scholssman et al.
patent: 5071964 (1991-12-01), Dustin et al.
patent: 5235049 (1993-08-01), McClelland
patent: 5284931 (1994-02-01), Springer et al.
patent: 5292636 (1994-03-01), Kung et al.
patent: 5475091 (1995-12-01), Springer et al.
Masroor et al. Transplant. Immunol. 2: 176-189 (1994).
Ward et al. Therapeutic Immunol. 1: 165-171 (1994).
Harris Tibtech 11: 42-44 (1993).
Winter et al. Tips 14: 139-143 (1993).
Edgington Biotechnology 10: 383-389 (1992).
Wee et al. Transplantation 58: 261-264 (1994).
Tufveson Immunol. Reviews 136: 99-109 (1993).
McCabe Cell Immunol. 150:364-375 (1993).
Waldmann Ann Rev Immunol. 7: 407-444 (1989).
Stoppa et al Transplant Int. 4: 3-7 (1991).
Hutchings et al. Nature 348: 639-642 (1990).
Tilney et al. Transplantation 52: 389-398 (1991).
Benjamin et al Eur J. Immunol. 18:1079-1088 (1988).
Shizuru et al Science 240: 659-662 (1993).
Campbell et al. PNAS 86: 4282-4286 (1989).
Armitage et al., "The Clinical Trial of FK 506 as Primary and Rescue Immunosuppression in Pediatric Cardiac Transplantation" Transplantation Proceedings 23 (6):3058-3060 (Dec. 1991).
Babany et al., "Evaluation of the in vivo Dose-Response Relationship of Immunosupressive Drugs Using a Mouse Heart Transplant Model: Application of Cyclosporine" The Journal of Pharmacology and Experimental Therapeutics 244 (1):259-262 (1988).
Barker et al., "Keratinocytes as Initiators of Inflammation" Lancet 337:211-214 (Jan. 26, 1991).
Baume et al., "Failure of a CD18/Anti-LFA1 Monclonal Antibody Infusion to Prevent Graft Rejection in Leukemic Patients Receiving T-Depleted Allogeneic Bone Marrow Transplantation" Transplantation 47 (3): 472-474 (Mar. 1989).
Benjamin et al., "Mechanisms of Monoclonal Antibody-Facilitated Tolerance Induction: A Possible Role for the DC4 (L3T4) and CD11a (LFA-1) Molecules in Self-Non-self Discrimination" European Journal of Immunology 18:1079-1088 (1988).
Berlin et al., "Monoclonal Antibodies Against Human T Cell Adhesion Molecules-Modulation of Immune Function in Nonhuman Primates" Transplantation 53(4):840-849 (1992).
Blakeslee, "New Technique in Lab Prevents Rejection of Organ Transplants" The New York Times p. B6 (Mar. 10, 1992).
Busing et al., "Is Long-Term Therapy Without Cyclosporin A (CsA) Indispensable or Dangerous? One-Year Results of a Prospective Randomized Trial" Transplantation Proceedings 21(1):1601-1603 (Feb. 1989).
Campbell, "Intercellular Adhesion Molecule 1 is Induced on Isolated Endocrine Islet Cells by Cytokines but not by Reovirus Infection" Proc. Natl. Acad. Sci. USA 86:4282-4286 (1989).
Carpenter et al., "Prophylactic Use of Monoclonal Anti-IL-2 Receptor Antibody in Cadaveric Renal Transplantation" American Journal of Kidney Diseases XIV(5):54-57 (Nov. 1989).
Cobbold et al., "Therapy With Monoclonal Antibodies by Elimination of T-cell subsets in vivo" Nature 312 (6):548-551 (Dec. 1984).
Cosimi et al., "Immunosuppression of Cynomolgus Receipients of Renal Allografts to R6.5, a Monoclonal Antibody to Intercellular Adhesion Molecule-1" In Leukocyte Adhesion Molecules, Springer-Verlag pp. 274-281 (1988).
Cosimi et al., "In Vivo Effects of Monoclonal Antibody to ICAM-1 (CD54) in Nonhuman Primates with Renal Allografts" The Journal of Immunology 144 (12):4604-4612 (Jun. 15, 1990).
Cunningham, "Anomolous Features of Allogeneic Reactions" Understanding Immunology (Chapter 10), New York: Academic Press pp. 158-159 (1978).
Cyclosporine Label, "Product Information" Physicians Desk Reference 49 (1995).
Dantal et al., "Use of Monoclonal Antibodies in Human Transplantation" Current Opinion in Immunology 3:740-747 (1991).
Davignon et al., "Monoclonal Antibody to a Novel Lymphocyte Function-Associated Antigen (LFA-1): Mechanism of Blockade of T Lymphocyte-Mediated Killing and Effects on Other T and B Lymphocyte Functions" The Journal of Immunology 127(2):590-595 (Aug. 1981).
Dustin et al., "Induction By IL 1 and Interferon-.gamma.: Tissue Distribution, Biochemistry, and Function of a Natural Adherence Molecule (ICAM-1).sup.1 " The Journal of Immunology 137 (1):245-254 (Jul. 1, 1986).
Edgington, "How Sweet It Is: Selection-Mediating Drugs" Bio/Technology 10:383-389 (Apr. 1992).
Fekete et al., "Involvement of Lyphocyte Function-Associated Antigen-1 (LFA-1.sub.-- But Not ICAM-1 in a Radioactive Leukocyte Cell-Mediated Immunity LA-CMI) Assay" J. Clin. Lab. Immunol. 31:145-149 (1990).
First et al. Clin. Transplant 2:185-189 (1988).
Fischer, "Anti-LFA-1 Antibody as Immunosuppressive Reagent in Transplantation" Chem. Immunol. 50:89-97 (1991).
Fischer et al., "Prevention of Graft Failure by an Anti-HLFA-1 Monoclonal Antibody in HLA-Mismatched Bone-Marrow Transplantation" Lancet pp. 1058-1061 (Nov. 8, 1986).
Fischer et al., "Reduction of Graft Failure by a Monoclonal Antibody (Anti-LFA-1 CD11a) After HLA Nonidentical Bone Marrow Transplantation in Children with Immunodeficiencies" Blood 77 (2):249-256 (Jan. 15, 1991).
Fischer et al., "Role of the LFA-1 Molecule in Cellular Interactions Required For Antibody Production in Humans.sup.1 " The Journal of Immunology 136 (9):3198-3203 (May 1, 1986).
Goebeler et al., "Expression of Intercellular Adhesion Molecule-1 in Murine Allergic Contact Dermatitis" Int. Arch. Allergy Appl. Immunol. 93:294-299 (1990).
Harris et al., "Therapeutic Antibodies--The Coming of Age" TIBTECH 11:42-44 (Feb. 1993).
Heagy et al., "Potent Ability of Anti-LFA-1 Monoclonal Antibody to Prolong Allograft Survival" Transplantation 37:520-523 (1984).
Herbert et al., "Strategies of Monoclonal Antibody Therapy That Induce Permanent Tolerance of Organ Transplants" Transplantation 46:128S-134S (Aug. 1988).
Hildreth et al., "A Human Lymphocyte-associated Antigen Involved in Cell-mediated Lympholysis" European Journal of Immunology 13:202-208 (1983).
Hourmant et al., "Administration of an Anti-CD11a Monoclonal Antibody in Recipients of Kidney Transplantation" Transplantation 58 (3):377-380 (Aug. 1994).
Hutchings et al., "Transfer of Diabetes in Mice Prevented by Blockade of Adhesion-Promoting Receptor on Macrophages" Nature 348:639-642 (Dec. 13, 1990).
Isaacs et al., "Humanised Monoclonal Antibody Therapy for Rheumatoid Arthritis" Lancet 340:748-752 (Sep. 26, 1992).
Isobe et al., "Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-I and LFA-1" Science pp. 1125-1127 (Feb. 1992).
Jendrisak et al., "Prolongation in Murine Cardiac Allograft Survival With Monoclonal Antibodies to LFA-1, ICAM-1, and CD4" Transplantation Proceedings 25 (1):825-827 (Feb. 1993).
Jensen et al., "Pediatric Renal Transplantation Under FK 506 Immunosuppression" Transplantation Proceedings 23 (6):3075-3077 (Dec. 1991).
Kahana et al., "OKT3 Prophylaxis Versus Conventional Drug Therapy: Single-Center Perspective, Part of a Multicenter Trial" American Journal of Kidney Diseases XIV (5):5-9 (Nov. 1989).
Komori et al., "Role of ICAM-1 and LFA-1 in Cardiac Allograft Rejection of the Rat" Transplantation Proceedings 25 (1):831-832 (Feb. 1993).
Krensky et al., "The Functional Significance, Distibution, and Structure of LFA-2, and LFA-3: Cell Surface Antigens Associated with CTL-Target Interactions.sup.1 " The Journal of Immunology 131 (2):611-616 (Aug. 1983).
Kuypers et al., "Leukocyte Membrane Adhesion Proteins LFA-1, CR3 and p150,95: A Review of Functional and Regulatory Aspects" Res. Immunol. 140:461-486 (1989).
Lakey et al., "Prevention of Recurrence of Insulin-Dependent Diabetes Mellitus in Islet Cell-Transplanted Diabetic NOD Mice Using Adjuvant Therapy" Transplantation Proceedings 24 (6):2848 (Dec. 1992).
Larson et al., "Structure and Function of Leukocyte Integrins" Immunological Reviews 114:181-217 (1990).
LeMa
Jardieu Paula M.
Montgomery Bruce
Chan Christina Y.
Gambel Phillip
Genentech Inc.
Lee Wendy M.
LandOfFree
Method for treating a LFA-1-mediated disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating a LFA-1-mediated disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating a LFA-1-mediated disorder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339777